Requires health benefits coverage for treatment of lipedema.
What changed between versions
Subsection d across all covered entity types (hospital service corporations, medical service corporations, health service corporations, individual and group health insurance policies, individual and small employer health benefits plans, HMOs, and State/School Employees Health Benefits Program contracts) was amended to remove the specific one-year prior authorization validity period, the prohibition on revocation or restriction within that period, and the requirement to honor prior authorizations from previous carriers. These were replaced with a single reference stating prior authorization shall be in accordance with requirements under the Ensuring Transparency in Prior Authorization Act (C.17B:30-55.1 et seq.).
The entire explanatory STATEMENT section at the end of the bill was removed, which had described the original provisions including the one-year prior authorization validity and portability requirements.
Header updated from 'Introduced Pending Technical Review' to 'As reported by the Senate Commerce Committee on May 18, 2026, with amendments,' and bill designation changed to S374 1R (First Reprint).